Literature DB >> 8408878

Membrane protein expression by Actinobacillus actinomycetemcomitans in response to iron availability.

J L Winston1, C K Chen, M E Neiders, D W Dyer.   

Abstract

Iron-limited growth conditions under anaerobiosis were established for Actinobacillus actinomycetemcomitans strains Y4, JP2, and 75 by use of the ferrous ion chelator 2,2'-dipyridyl. Growth inhibition was reversible with both ferrous and ferric iron sources. Sarcosyl-insoluble membrane fractions of iron-stressed anaerobic A. actinomycetemcomitans cultures revealed a similar iron-repressible protein of approximately 70 kDa in A. actinomycetemcomitans strains Y4, JP2, and 75. This 70-kDa protein was recognized by serum from localized juvenile periodontitis patients and a periodontally healthy subject. This suggested that the 70-kDa iron-repressible protein may be expressed in vivo. When A. actinomycetemcomitans was grown under aerobic conditions, the ferric iron chelator, ethylenediamine di(o-hydroxyphenylacetic acid) (EDDA) was utilized for growth limitation. EDDA inhibition was reversible in strain Y4 with ferrous and ferric iron sources. An iron-repressible protein of approximately 70 kDa was also noted in iron-stressed aerobic cultures. The 70-kDa protein may be involved in iron transport by A. actinomycetemcomitans. Preliminary experiments were performed to examine potential iron transport systems for A. actinomycetemcomitans. Production of the two most common chemical types of siderophore was not detected in A. actinomycetemcomitans culture supernatants. Iron-starved A. actinomycetemcomitans cells did not bind transferrin or lactoferrin in a dot blot assay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408878     DOI: 10.1177/00220345930720100501

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  9 in total

1.  Characterization of a periplasmic protein involved in iron utilization of Actinobacillus actinomycetemcomitans.

Authors:  P T Willemsen; I Vulto; M Boxem; J de Graaff
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

2.  Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.

Authors:  Nataliya V Balashova; Roger Diaz; Sergey V Balashov; Juan A Crosby; Scott C Kachlany
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

3.  Genetic and functional analyses of the Actinobacillus actinomycetemcomitans AfeABCD siderophore-independent iron acquisition system.

Authors:  Eric R Rhodes; Andrew P Tomaras; Glen McGillivary; Pamela L Connerly; Luis A Actis
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 4.  Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.

Authors:  S C Kachlany
Journal:  J Dent Res       Date:  2010-03-03       Impact factor: 6.116

5.  Cloning, expression, and sequencing of a protease gene from Bacteroides forsythus ATCC 43037 in Escherichia coli.

Authors:  T Saito; K Ishihara; T Kato; K Okuda
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media.

Authors:  P W Whitby; K E Sim; D J Morton; J A Patel; T L Stull
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  Molecular cloning of the fur gene from Actinobacillus actinomycetemcomitans.

Authors:  V I Haraszthy; E T Lally; G G Haraszthy; J J Zambon
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

8.  The Hunger Games: Aggregatibacter actinomycetemcomitans Exploits Human Neutrophils As an Epinephrine Source for Survival.

Authors:  Hazel Ozuna; Silvia M Uriarte; Donald R Demuth
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 8.786

9.  Microbial Community Composition Impacts Pathogen Iron Availability during Polymicrobial Infection.

Authors:  Apollo Stacy; Nader Abraham; Peter Jorth; Marvin Whiteley
Journal:  PLoS Pathog       Date:  2016-12-14       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.